Adamas Pharmaceuticals Inc. buy marge
Start price
07.09.17
/
50%
€19.52
Target price
09.04.19
€37.88
Performance (%)
-68.62%
End price
09.04.19
€6.12
Summary
This prediction ended on 09.04.19 with a price of €6.12. The BUY prediction by marge for Adamas Pharmaceuticals Inc. performed very badly with a performance of -68.62%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
Comments by marge for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
marge stimmt der Buy-Einschätzung von klostergang zu
marge stimmt am 07.09.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 32$ zu.
Überschrift: Adamas's ADS-5102 could become the first FDA approved drug for Parkinson's disease
(Vom Mitglied beendet)